Windlas Biotech’s board approved the unaudited standalone and consolidated results for Q3 FY2025-26 (quarter and nine months ended Dec 31, 2025), with a limited review report by the auditors.
AI Assistant
Windlas Biotech Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.